OCI-AML-5

Leukemia/

Lymphoma

OCI-AML-5 was derived from a 77 year old man with acute myeloid leukemia in relapse

Notes

OCI-AML-5 cells respond to G-CSF, GM-CSF, IL-3, and FLT3 ligand

in vivo

Used in allogeneic xenografts

Tumors grow in nude mice

Request Quote

Receive a quote within one business day